Year-over-year, this metric declined by 100.0%, from $250.00K to $0.00.
An increase indicates active inorganic growth and investment in market share, while zero or low values suggest a focus on organic growth or lack of M&A activity.
Represents the value of goodwill recognized during the acquisition of businesses within the North American pharmaceutica...
Commonly reported by large-scale pharmaceutical wholesalers and healthcare distributors during periods of industry consolidation.
mck_segment_north_american_pharmaceutical_goodwill_acquired| FY'25 | FY'26 | |
|---|---|---|
| Value | $1.00M | $0.00 |
| YoY Change | — | -100.0% |